The Pediatric Clinical Trial Market is anticipated to expand at a CAGR of 5.9% during the projected period. The market value is projected to increase from USD 17,918.1 million in 2024 to USD 31,661.0 million by 2034. The market was valued at USD 16,831.0 million in 2023 and grew at a CAGR of 6.5% from 2019 to 2023.
Attributes | Details |
---|---|
Pediatric Clinical Trial Market Value (2024) | USD 17,918.1 million |
Projected Market Value (2034) | USD 31,661.0 million |
CAGR (2024 to 2034) | 5.9% |
Due to the pediatric population's unmet healthcare needs, there is a sizable product pipeline in the clinical development phase. The pediatric clinical trial market is likely to acquire a strong pipeline for developing new medications shortly.
The market is driven by the rising awareness of pediatric medicines, outsourcing internal clinical trials to CROs, and the rising prevalence of pediatric diseases like diabetes. North America is expected to dominate the market during the projection period.
The growing prevalence of illnesses in the pediatric population bolsters clinical trials and research efforts to develop specific drugs. The demand for pediatric clinical trials is driven by various factors in the global market.
Attributes | Details |
---|---|
Market Value for 2019 | USD 14,118.8 million |
Market Value for 2023 | USD 16,831.0 million |
Market CAGR from 2019 to 2023 | 4.4% |
Leading Area | Oncology |
---|---|
Market Share in 2024 | 21.8% |
Leading Sponsor | Industry |
---|---|
Market Share in 2024 | 50.7% |
Leading Phase | Phase 3 |
---|---|
Segment CAGR | 46.9% |
The pediatric clinical trial market can be observed in the subsequent tables, which focus on the leading economies in India, China, France, Germany, and the United States. A comprehensive evaluation demonstrates that India has enormous opportunities due to its resilient pediatric clinical trial manufacturers.
Countries | CAGR (2024 to 2034) |
---|---|
India | 14.1% |
China | 11.7% |
France | 7.1% |
United States | 3% |
Germany | 2.5% |
Leading pediatric clinical trial providers, such as Synteract, ICON Plc., Syneos Health, Medpace, Inc., PPD Inc., Premier Research, LabCorp Drug Development, QPS Holding, Pfizer Inc., and The Emmes Company, LLC, as well as IQVIA Inc., dominate the competitive landscape.
These pediatric clinical trial vendors use their resources and experience in pediatric healthcare research to drive innovation and determine the sector's course.
Notable industry leaders in pediatric pharmaceutical trials, Synteract, ICON Plc., and Syneos Health, are renowned for their broad skills and all-inclusive services. With their specialist solutions, Medpace, Inc., PPD Inc., and Premier Research enhance the competitive landscape with substantial knowledge.
The market is strengthened and diversified by the acquisition of LabCorp Drug Development, QPS Holding, and Pfizer Inc., which enhances the pediatric clinical trial ecosystem.
The Emmes Company, LLC and IQVIA Inc. contribute breadth and depth, guaranteeing a vibrant and competitive atmosphere that promotes ongoing advancement and creativity in pediatric healthcare research.
Notable Developments
Company | Details |
---|---|
Thermo Fisher Scientific Inc. | The National Minority Quality Forum (NMQF), an independent non-profit organization dedicated to research and education, and Thermo Fisher Scientific Inc., a leader in the science service industry worldwide, announced in September 2023 that they collaborated to support the expansion of clinical research to historically underserved patient populations through the NMQF's Alliance for Representative Clinical Trials (ARC). |
Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. and Chicago, Illinois-based SAMDI Tech, Inc. announced in January 2022 that they were expanding their strategic alliance. As part of the current relationship, which was formed in 2018, SAMDI Tech clients can use Charles River's collection of lead-like compounds for high-throughput screening (HTS). |
Pfizer | In August 2022, Pfizer presented positive top-line results from its pivotal Phase 3 study on infants in the United States. The study assessed the efficacy of Pfizer's 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for preventing invasive pneumococcal disease (IPD) in pediatric patients by evaluating its 20 Streptococcus pneumoniae serotypes. |
Sanofi | Among children with eosinophilic esophagitis (EoE) aged 1 to 11, Sanofi's Phase 3 trial produced encouraging results in July 2022. For children with EoE under the age of 12, there are no recognized treatments. |
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Region
Table 06: North America Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 07: North America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 08: North America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 09: North America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 10: Latin America Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 11: Latin America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 12: Latin America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 13: Latin America Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 14: East Asia Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 15: East Asia Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 16: East Asia Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 17: East Asia Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 18: South Asia & Pacific Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 19: South Asia & Pacific Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 20: South Asia & Pacific Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 21: South Asia & Pacific Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 22: Western Europe Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 23: Western Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 24: Western Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 25: Western Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 26: Eastern Europe Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 27: Eastern Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 28: Eastern Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 29: Eastern Europe Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Table 30: Middle East & Africa Market Value (US$ Million) Analysis 2018 to 2023 and Forecast 2024 to 2034, by Country
Table 31: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Area
Table 32: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by Sponsor
Table 33: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2018 to 2034, by End User
Figure 1: Global Market Value (US$ Million) Analysis, 2018 to 2023
Figure 2: Global Market Forecast & Y-o-Y Growth, 2024 to 2034
Figure 3: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2023 to 2034
Figure 4: Global Market Value Share (%) Analysis 2023 to 2034, by Area
Figure 5: Global Market Y-o-Y Growth (%) Analysis 2023 to 2034, by Area
Figure 6: Global Market Attractiveness Analysis 2024 to 2034, by Area
Figure 7: Global Market Value Share (%) Analysis 2023 to 2034, by Sponsor
Figure 8: Global Market Y-o-Y Growth (%) Analysis 2023 to 2034, by Sponsor
Figure 9: Global Market Attractiveness Analysis 2024 to 2034, by Sponsor
Figure 10: Global Market Value Share (%) Analysis 2023 to 2034, by Phase
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2023 to 2034, by Phase
Figure 12: Global Market Attractiveness Analysis 2024 to 2034, by Phase
Figure 13: Global Market Value Share (%) Analysis 2023 to 2034, by Region
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2023 to 2034, by Region
Figure 15: Global Market Attractiveness Analysis 2024 to 2034, by Region
Figure 16: North America Market Value (US$ Million) Analysis, 2018 to 2023
Figure 17: North America Market Value (US$ Million) Forecast, 2023 to 2034
Figure 18: North America Market Value Share, by Area (2024 E)
Figure 19: North America Market Value Share, by Sponsor (2024 E)
Figure 20: North America Market Value Share, by Phase (2024 E)
Figure 21: North America Market Value Share, by Country (2024 E)
Figure 22: North America Market Attractiveness Analysis by Area, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 25: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 26: USA Market Value Proportion Analysis, 2023
Figure 27: Global Vs. USA Growth Comparison, 2023 to 2034
Figure 28: USA Market Share Analysis (%) by Area, 2023 to 2034
Figure 29: USA Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 30: USA Market Share Analysis (%) by Phase, 2023 to 2034
Figure 31: Canada Market Value Proportion Analysis, 2023
Figure 32: Global Vs. Canada. Growth Comparison, 2023 to 2034
Figure 33: Canada Market Share Analysis (%) by Area, 2023 to 2034
Figure 34: Canada Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 35: Canada Market Share Analysis (%) by Phase, 2023 to 2034
Figure 36: Mexico Market Value Proportion Analysis, 2023
Figure 37: Global Vs. Mexico Growth Comparison, 2023 to 2034
Figure 38: Mexico Market Share Analysis (%) by Area, 2023 to 2034
Figure 39: Mexico Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 40: Mexico Market Share Analysis (%) by Phase, 2023 to 2034
Figure 41: Latin America Market Value (US$ Million) Analysis, 2018 to 2023
Figure 42: Latin America Market Value (US$ Million) Forecast, 2023 to 2034
Figure 43: Latin America Market Value Share, by Area (2024 E)
Figure 44: Latin America Market Value Share, by Sponsor (2024 E)
Figure 45: Latin America Market Value Share, by Phase (2024 E)
Figure 46: Latin America Market Value Share, by Country (2024 E)
Figure 47: Latin America Market Attractiveness Analysis by Area, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 49: Latin America Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 50: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 51: Brazil Market Value Proportion Analysis, 2023
Figure 52: Global Vs. Brazil. Growth Comparison, 2023 to 2034
Figure 53: Brazil Market Share Analysis (%) by Area, 2023 to 2034
Figure 54: Brazil Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 55: Brazil Market Share Analysis (%) by Phase, 2023 to 2034
Figure 56: Chile Market Value Proportion Analysis, 2023
Figure 57: Global Vs. Chile Growth Comparison, 2023 to 2034
Figure 58: Chile Market Share Analysis (%) by Area, 2023 to 2034
Figure 59: Chile Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 60: Chile Market Share Analysis (%) by Phase, 2023 to 2034
Figure 61: East Asia Market Value (US$ Million) Analysis, 2018 to 2023
Figure 62: East Asia Market Value (US$ Million) Forecast, 2023 to 2034
Figure 63: East Asia Market Value Share, by Area (2024 E)
Figure 64: East Asia Market Value Share, by Sponsor (2024 E)
Figure 65: East Asia Market Value Share, by Phase (2024 E)
Figure 66: East Asia Market Value Share, by Country (2024 E)
Figure 67: East Asia Market Attractiveness Analysis by Area, 2024 to 2034
Figure 68: East Asia Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 69: East Asia Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 70: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 71: China Market Value Proportion Analysis, 2023
Figure 72: Global Vs. China Growth Comparison, 2023 to 2034
Figure 73: China Market Share Analysis (%) by Area, 2023 to 2034
Figure 74: China Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 75: China Market Share Analysis (%) by Phase, 2023 to 2034
Figure 76: Japan Market Value Proportion Analysis, 2023
Figure 77: Global Vs. Japan Growth Comparison, 2023 to 2034
Figure 78: Japan Market Share Analysis (%) by Area, 2023 to 2034
Figure 79: Japan Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 80: Japan Market Share Analysis (%) by Phase, 2023 to 2034
Figure 81: South Korea Market Value Proportion Analysis, 2023
Figure 82: Global Vs South Korea Growth Comparison, 2023 to 2034
Figure 83: South Korea Market Share Analysis (%) by Area, 2023 to 2034
Figure 84: South Korea Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 85: South Korea Market Share Analysis (%) by Phase, 2023 to 2034
Figure 86: South Asia & Pacific Market Value (US$ Million) Analysis, 2018 to 2023
Figure 87: South Asia & Pacific Market Value (US$ Million) Forecast, 2023 to 2034
Figure 88: South Asia & Pacific Market Value Share, by Area (2024 E)
Figure 89: South Asia & Pacific Market Value Share, by Sponsor (2024E)
Figure 90: South Asia & Pacific Market Value Share, by Phase (2024 E)
Figure 91: South Asia & Pacific Market Value Share, by Country (2024 E)
Figure 92: South Asia & Pacific Market Attractiveness Analysis by Area, 2024 to 2034
Figure 93: South Asia & Pacific Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 94: South Asia & Pacific Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 95: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 96: India Market Value Proportion Analysis, 2023
Figure 97: Global Vs. India Growth Comparison, 2023 to 2034
Figure 98: India Market Share Analysis (%) by Area, 2023 to 2034
Figure 99: India Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 100: India Market Share Analysis (%) by Phase, 2023 to 2034
Figure 101: ASEAN Countries Market Value Proportion Analysis, 2023
Figure 102: Global Vs. ASEAN Countries Growth Comparison, 2023 to 2034
Figure 103: ASEAN Countries Market Share Analysis (%) by Area, 2023 to 2034
Figure 104: ASEAN Countries Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 105: ASEAN Countries Market Share Analysis (%) by Phase, 2023 to 2034
Figure 106: Australia & New Zealand Market Value Proportion Analysis, 2023
Figure 107: Global Vs. Australia & New Zealand Growth Comparison, 2023 to 2034
Figure 108: Australia & New Zealand Market Share Analysis (%) by Area, 2023 to 2034
Figure 109: Australia & New Zealand Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 110: Australia & New Zealand Market Share Analysis (%) by Phase, 2023 to 2034
Figure 111: Western Europe Market Value (US$ Million) Analysis, 2018 to 2023
Figure 112: Western Europe Market Value (US$ Million) Forecast, 2023 to 2034
Figure 113: Western Europe Market Value Share, by Area (2024 E)
Figure 114: Western Europe Market Value Share, by Sponsor (2024 E)
Figure 115: Western Europe Market Value Share, by Phase (2024 E)
Figure 116: Western Europe Market Value Share, by Country (2024 E)
Figure 117: Western Europe Market Attractiveness Analysis by Area, 2024 to 2034
Figure 118: Western Europe Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 119: Western Europe Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 120: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: UK Market Value Proportion Analysis, 2023
Figure 122: Global Vs. UK Growth Comparison, 2023 to 2034
Figure 123: UK Market Share Analysis (%) by Area, 2023 to 2034
Figure 124: UK Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 125: UK Market Share Analysis (%) by Phase, 2023 to 2034
Figure 126: Germany Market Value Proportion Analysis, 2023
Figure 127: Global Vs. Germany Growth Comparison, 2023 to 2034
Figure 128: Germany Market Share Analysis (%) by Area, 2023 to 2034
Figure 129: Germany Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 130: Germany Market Share Analysis (%) by Phase, 2023 to 2034
Figure 131: Italy Market Value Proportion Analysis, 2023
Figure 132: Global Vs. Italy Growth Comparison, 2023 to 2034
Figure 133: Italy Market Share Analysis (%) by Area, 2023 to 2034
Figure 134: Italy Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 135: Italy Market Share Analysis (%) by Phase, 2023 to 2034
Figure 136: France Market Value Proportion Analysis, 2023
Figure 137: Global Vs France Growth Comparison, 2023 to 2034
Figure 138: France Market Share Analysis (%) by Area, 2023 to 2034
Figure 139: France Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 140: France Market Share Analysis (%) by Phase, 2023 to 2034
Figure 141: Spain Market Value Proportion Analysis, 2023
Figure 142: Global Vs Spain Growth Comparison, 2023 to 2034
Figure 143: Spain Market Share Analysis (%) by Area, 2023 to 2034
Figure 144: Spain Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 145: Spain Market Share Analysis (%) by Phase, 2023 to 2034
Figure 146: Nordic Countries Market Value Proportion Analysis, 2023
Figure 147: Global Vs Nordic Countries Growth Comparison, 2023 to 2034
Figure 148: Nordic Countries Market Share Analysis (%) by Area, 2023 to 2034
Figure 149: Nordic Countries Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 150: Nordic Countries Market Share Analysis (%) by Phase, 2023 to 2034
Figure 151: BENELUX Market Value Proportion Analysis, 2023
Figure 152: Global Vs BENELUX Growth Comparison, 2023 to 2034
Figure 153: BENELUX Market Share Analysis (%) by Area, 2023 to 2034
Figure 154: BENELUX Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 155: BENELUX Market Share Analysis (%) by Phase, 2023 to 2034
Figure 156: Eastern Europe Market Value (US$ Million) Analysis, 2018 to 2023
Figure 157: Eastern Europe Market Value (US$ Million) Forecast, 2023 to 2034
Figure 158: Eastern Europe Market Value Share, by Area (2024 E)
Figure 159: Eastern Europe Market Value Share, by Sponsor (2024 E)
Figure 160: Eastern Europe Market Value Share, by Phase (2024 E)
Figure 161: Eastern Europe Market Value Share, by Country (2024 E)
Figure 162: Eastern Europe Market Attractiveness Analysis by Area, 2024 to 2034
Figure 163: Eastern Europe Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 164: Eastern Europe Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 165: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 166: Russia Market Value Proportion Analysis, 2023
Figure 167: Global Vs. Russia Growth Comparison, 2023 to 2034
Figure 168: Russia Market Share Analysis (%) by Area, 2023 to 2034
Figure 169: Russia Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 170: Russia Market Share Analysis (%) by Phase, 2023 to 2034
Figure 171: Hungary Market Value Proportion Analysis, 2023
Figure 172: Global Vs Hungary Growth Comparison, 2023 to 2034
Figure 173: Hungary Market Share Analysis (%) by Area, 2023 to 2034
Figure 174: Hungary Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 175: Hungary Market Share Analysis (%) by Phase, 2023 to 2034
Figure 176: Poland Market Value Proportion Analysis, 2023
Figure 177: Global Vs Poland Growth Comparison, 2023 to 2034
Figure 178: Poland Market Share Analysis (%) by Area, 2023 to 2034
Figure 179: Poland Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 180: Poland Market Share Analysis (%) by Phase, 2023 to 2034
Figure 181: Middle East & Africa Market Value (US$ Million) Analysis, 2018 to 2023
Figure 182: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2034
Figure 183: Middle East & Africa Market Value Share, by Area (2024 E)
Figure 184: Middle East & Africa Market Value Share, by Sponsor (2024E)
Figure 185: Middle East & Africa Market Value Share, by Phase (2024 E)
Figure 186: Middle East & Africa Market Value Share, by Country (2024 E)
Figure 187: Middle East & Africa Market Attractiveness Analysis by Area, 2024 to 2034
Figure 188: Middle East & Africa Market Attractiveness Analysis by Sponsor, 2024 to 2034
Figure 189: Middle East & Africa Market Attractiveness Analysis by Phase, 2024 to 2034
Figure 190: Middle East & Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 191: Saudi Arabia Market Value Proportion Analysis, 2023
Figure 192: Global Vs Saudi Arabia Growth Comparison, 2023 to 2034
Figure 193: Saudi Arabia Market Share Analysis (%) by Area, 2023 to 2034
Figure 194: Saudi Arabia Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 195: Saudi Arabia Market Share Analysis (%) by Phase, 2023 to 2034
Figure 196: Türkiye Market Value Proportion Analysis, 2023
Figure 197: Global Vs. Türkiye Growth Comparison, 2023 to 2034
Figure 198: Türkiye Market Share Analysis (%) by Area, 2023 to 2034
Figure 199: Türkiye Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 200: Türkiye Market Share Analysis (%) by Phase, 2023 to 2034
Figure 201: South Africa Market Value Proportion Analysis, 2023
Figure 202: Global Vs. South Africa Growth Comparison, 2023 to 2034
Figure 203: South Africa Market Share Analysis (%) by Area, 2023 to 2034
Figure 204: South Africa Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 205: South Africa Market Share Analysis (%) by Phase, 2023 to 2034
Figure 206: Other African Union Market Value Proportion Analysis, 2023
Figure 207: Global Vs Other African Union Growth Comparison, 2023 to 2034
Figure 208: Other African Union Market Share Analysis (%) by Area, 2023 to 2034
Figure 209: Other African Union Market Share Analysis (%) by Sponsor, 2023 to 2034
Figure 210: Other African Union Market Share Analysis (%) by Phase, 2023 to 2034
The pediatric clinical trial market is set to secure a valuation of USD 17,918.1 million in 2024.
The demand for pediatric clinical trials is estimated to attain USD 31,661.0 million by 2034.
Sales of pediatric clinical trials are anticipated to evolve at a 5.9% CAGR through 2034.
From 2019 to 2023, the pediatric clinical trial sales registered a 4.4% CAGR.
The oncology segment is set to achieve a market share of 21.8% in 2024.
The industry segment is expected to hold a 50.7% market share in 2024.
The phase 3 segment is set to achieve a market share of 46.9% in 2024.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.